34 Recruiting Large B-cell Lymphoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Large B-cell Lymphoma
Related Conditions
Top Recruiting Large B-cell Lymphoma Studies
An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma
📍 Alaska Oncology & Hematology, LLC — Anchorage, Alaska
View Study & Checklist ➔Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma
📍 Local Institution - 0014 — Mobile, Alabama
View Study & Checklist ➔Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Patients With Relapsed/Refractory Aggressive B Cell Lymphoma
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Golcadomide With Pemetrexed, Rituximab, and Dexamethasone for Relapsed and Refractory CNS Lymphomas
📍 Cleveland Clinic, Case Comprehensive Cancer Center — Cleveland, Ohio
View Study & Checklist ➔Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔CAR-T Followed by Bispecific Antibodies
📍 University of Nebraska Medical Center — Omaha, Nebraska
View Study & Checklist ➔A Study to Evaluate Zanubrutinib and Tislelizumab in Progressive Lymphoma Post CAR-T
📍 University Health Network (UHN) — Toronto, Ontario
View Study & Checklist ➔Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell Lymphoma
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL
📍 Research Site — Clayton,
View Study & Checklist ➔Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma
📍 University of Miami — Miami, Florida
View Study & Checklist ➔Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Emapalumab Prevention of CAR-T Cell Associated Toxicities
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔BHB & CAR-T for Lymphomas
📍 Abramson Cancer Center at University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔